IH can also promote the accumulation of the transcriptional activator hypoxia-inducible factor 1α (HIF-1α) [22], which is a key factor in the progression of prostate hyperplasia and a potential therapeutic target in BPH [23]. The gene discussed is HIF1A; the disease is benign prostatic hyperplasia.